Treatment patterns, the provision of health care and availability of funding have been influenced by the accession of Poland into the European Union. Poland represents a growing market for medical devices and other health care industries and is now the most preferred choice for manufacturers looking to expand operations into the newly emerging health care markets of Europe.
Based on published sources, Frost & Sullivan estimates that the size of the medical device market in Poland was $1,290.0 million in 2005.
Accession into the EU has proven to be highly beneficial in financial terms, with fund transfers from the EU poised to generate additional capital flows into Poland. In 2004, foreign direct investments into the country stood at nearly $7.9 billion, marking an increase of almost 23% from 2003. This also represented the highest increase of FDI into Poland over the last four years.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze